Literature DB >> 16752318

[Optic nerve drusen and deep visual fields defects].

C Calvo-González1, E Santos-Bueso, D Díaz-Valle, J Reche-Frutos, M Moriche-Carretero, J M Benítez-Del-Castillo, J García-Sánchez.   

Abstract

PURPOSE: Optic nerve drusen needs to be included in the differential diagnosis of pseudopapilledema. As the identification of this entity by funduscopy may be difficult, ultrasonography has thus become the gold standard for its diagnosis. Severe optic nerve drusen has been correlated with a reduction of the nerve fiber layer measured by optic coherence tomography and with the presence of serious visual field defects. To demonstrate the relationship between extensive optic nerve drusen and visual field defects.
METHOD: A prospective observational study of the visual fields of a series of 5 patients with severe optic nerve drusen diagnosed by ultrasonography.
RESULTS: Visual field defects of widely differing severity, from inferior nasal quadrant to severe hemivisual field defects, were described in each patient studied.
CONCLUSIONS: Visual field defects of diverse severity are common in patients with deep optic nerve drusen. For that reason ultrasonography and/or optical coherence tomography is highly recommended where such visual field defects exist.

Entities:  

Mesh:

Year:  2006        PMID: 16752318

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  3 in total

1.  Do Optic Disc Drusen Cause Unilateral Nyctalopia?

Authors:  Yi Wei Goh; Alex Buller
Journal:  Case Rep Ophthalmol       Date:  2010-10-09

2.  Visual field defects due to optic disk drusen in children.

Authors:  Susana Noval; Josep Visa; Inés Contreras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-04       Impact factor: 3.117

3.  Case report of optic disc drusen with simultaneous peripapillary subretinal hemorrhage and central retinal vein occlusion.

Authors:  David Zhiwei Law; Francine Pei Lin Yang; Stephen Charn Beng Teoh
Journal:  Case Rep Ophthalmol Med       Date:  2014-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.